A Retrospective Cohort Study on Treponema pallidum Infection: Clinical Trends and Treatment Outcomes for Congenital Syphilis in Guangxi, China (2013-2023)
DOI: https://doi.org/10.2147/idr.s467426
2024-06-13
Infection and Drug Resistance
Abstract:Sandip Patil, 1, 2, &ast Xinye Li, 3, &ast Pai Liu, 1 Yan Dai, 3 Xiyi Zhu, 3 Junjun Li, 3 Sixi Liu, 1 Feiqiu Wen 1, 2 1 Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China; 2 Paediatric Research Institute, Shenzhen Children's Hospital, Shenzhen, Guangdong Province, People's Republic of China; 3 Department of Paediatrics, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning City, Guangxi Zhuang Autonomous Region, People's Republic of China &astThese authors contributed equally to this work Correspondence: Feiqiu Wen, Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, People's Republic of China, Tel +86-755-83009888, Email Background: Syphilis, a prevalent sexually transmitted infection, poses severe risks, especially during pregnancy. This study aimed to elucidate the trends and impacts of syphilis in Guangxi, China, focusing on prevalence, clinical manifestations, and treatment outcomes in pregnant women and newborns. The objectives included understanding the demographic characteristics of affected pregnant women, analysing the clinical manifestations in newborns, and assessing the effectiveness of the treatment protocol. Methods: Conducted in adherence to ethical guidelines, a retrospective cohort study from January 2013 to December 2023 included 54,048 pregnant women tested for T. pallidum . Diagnosis involved a comprehensive approach, utilizing tests like the Toluidine Red Unheated Serum Test (TRUST) and the Treponema pallidum Particle Agglutination (TPPA) assay. Infant diagnosis and clinical manifestations were evaluated through a decade-long follow-up. Treatment protocols, including Benzathine penicillin, were implemented. Statistical analyses were conducted using SAS version 9.4. Results: Among 54,048 pregnant women, 0.10% were syphilis positive, correlating with a rise in hospitalizations. Newborns exhibited varied clinical manifestations, with neonatal pneumonia and jaundice being prevalent. The treatment protocol, especially with Benzathine penicillin, achieved a remarkable 100% cure success rate. The study noted a significant reduction in mother-to-child transmission. Syphilis in mothers and babies was diagnosed at different clinical stages, including primary, secondary, latent, and tertiary. Conclusion: This study underscores the escalating impact of syphilis on pregnant women and newborns in Guangxi, China. The findings highlight the necessity for robust preventive measures, early diagnosis, and effective treatment strategies. The observed 100% cure success rate with Benzathine penicillin emphasizes the importance of strict treatment protocols in mitigating the adverse effects of congenital syphilis and reducing its transmission. Keywords: congenital syphilis, mother-to-child transmission, diagnosis, antibiotic treatment Syphilis, a sexually transmitted infection caused by Treponema pallidum ( T. pallidum ) 1 remains a significant global health concern, contributing to the intricate landscape of sexually transmitted diseases (STIs). 2,3 The World Health Organization (WHO) estimates 18 to 36 million cases globally, with an annual incidence of 5.6 to 11.0 million new infections. 4,5 While predominantly affecting low-income and middle-income countries, a resurgence has been noted in high-income countries over two decades, emphasising an understanding of clinical trends and therapeutic approaches. 6 Untreated syphilis in pregnant women poses a risk to infants (congenital syphilis-CS), resulting in transmission to >70% of affected newborns and a 40% incidence of fetal or perinatal death. 7 The incidence of CS in the United States of America (USA)- Mississippi has a concerning rise by 1000% between 2016–2022. 8 In China, reported cases increased from 7.2 to 82.7 per 100,000 newborns between 2003–2011. Although this incidence declined to 27.6 per 100,000 newborns in 2016, it still exceeds the targeted goal of 15 cases per 100,000 for the year 2020. 9 This persistence emphasizes the need for sustained efforts to address and mitigate the rising incidence of CS in China. CS at $9969 per case highlights the urgency of precise diagnosis to prevent health complications and economic strain on families and communities. 10 National reports on CS cases remain limited. For every 4.6 pregnant women with syphilis, one case of CS emerged. 11 It is crucial for all neonates born to mothers with reactive test resul -Abstract Truncated-
pharmacology & pharmacy,infectious diseases